UNIVERSITÉ CATHOLIQUE DE LOUVAIN
100Patents
60Active
100Granted
53Portfolio score
Filing activity: Jan 18, 1984 → May 15, 2023 · 10 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8854457B2 | Systems and methods for the autonomous production of videos from multi-sensored data | Electricity | 118 | Active |
| US5962136A | Biomaterial and method for obtaining it | Emerging Cross-Sectional Technologies | 110 | Expired |
| US4789735A | Conjugate constituted from a wall adhesin of S. mutans of proteinic nature and from a polysaccharide of S. mutans, its preparation and its use particularly in anti-caries vaccines | Emerging Cross-Sectional Technologies | 64 | Expired |
| US5962216A | Tumor-activated prodrug compounds and treatment | Human Necessities | 51 | Expired |
| US4956219A | method of producing perforations in a solid material in sheet form, an irradiation device for working the method, and the resulting perforated material | Performing Operations; Transporting | 32 | Expired |
| US6342480B1 | Tumor-activated prodrug compounds and treatment | Human Necessities | 29 | Expired |
| US7943394B2 | Method and device for high sensitivity detection of the presence of DNA and other probes | Emerging Cross-Sectional Technologies | 27 | Active |
| US4637916A | Sterilization method employing a circulating gaseous sterilant | Human Necessities | 25 | Expired |
| US5951983A | Methods of inhibiting T cell mediated immune responses with humanized LO-CD2A-specific antibodies | Chemistry; Metallurgy | 23 | Expired |
| US4764351A | Sterilization method and apparatus using a gaseous agent | Human Necessities | 22 | Expired |
| US5939270A | Markers for organ rejection | Emerging Cross-Sectional Technologies | 17 | Expired |
| US6407063B1 | Tumor antigens and CTL clones isolated by a novel procedure | Human Necessities | 16 | Expired |
| US7585748B2 | Process for manufacturing a multilayer structure made from semiconducting materials | Electricity | 16 | Active |
| US5817311A | Methods of inhibiting T-cell medicated immune responses with LO-CD2a-specific antibodies | Chemistry; Metallurgy | 15 | Expired |
| US5730979A | LO-CD2a antibody and uses thereof for inhibiting T cell activation and proliferation | Chemistry; Metallurgy | 12 | Expired |
| US5965381A | Delivery of proteins into eukaryotic cells with recombinant yersinia | Chemistry; Metallurgy | 11 | Expired |
| US6870229B2 | Ultra-low power basic blocks and their uses | Electricity | 9 | Expired |
| US8294492B2 | Ultra-low-power circuit | Electricity | 7 | Active |
| US6531451B1 | Tumor antigens and CTL clones isolated by a novel procedure | Human Necessities | 7 | Expired |
| US8673635B2 | Isolated liver stem cells | Physics | 6 | Active |
| US7108846B1 | Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection | Chemistry; Metallurgy | 6 | Expired |
| US6714079B2 | Differential amplifier with gain substantially independent of temperature | Electricity | 6 | Expired |
| US7362140B2 | Low swing current mode logic family | Electricity | 6 | Expired |
| US6861006B2 | Method for creating pores in a polymer material | Emerging Cross-Sectional Technologies | 5 | Expired |
| US9181265B2 | Substituted 2,3-dihydro-1H-benzo[a]pyrano[2,3-c]phenazines as anti-angiogenic and anti-cancer agents | Chemistry; Metallurgy | 5 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.